![]() |
市场调查报告书
商品编码
1926499
如何在营养保健品产业中驾驭女性健康成分市场Navigating the Women's Health Ingredients Market in the Nutraceutical Industry |
||||||
产业对女性健康的日益关注推动了变革性成长
儘管女性健康领域已成为整个健康产业中成长最快的细分市场之一,但仍面临许多挑战。长期以来,女性在临床试验中的参与度一直偏低,导致缺乏针对女性健康状况的特定数据。由于许多营养保健品和药品主要针对男性进行研究,因此人们对这些产品如何对女性产生不同影响缺乏了解,从而导致误诊、治疗无效和副作用。根据世界经济论坛发布的《2024年消除女性健康差距》报告,在美国,女性服用已获已通过核准药物后出现不利事件的机率比男性高52%,严重或致命不良反应的机率高36%。报告也指出,女性经历健康状况不佳的年资比男性多25%。该行业面临的挑战在于,如何透过开发对女性安全有效的产品来消除这种差距,尤其是在生殖健康、荷尔蒙平衡和更年期骨骼健康等领域。
《全球女性健康营养保健品成分市场》研究报告聚焦在女性在各个生命阶段(从青春期、生育期到更年期后)的特定营养需求。该市场蕴藏着丰富的机会,预计在预测期(2025-2031年)内将维持强劲成长。
Increasing Industry Focus on Women's Health Driving Transformational Growth
The women's health space is emerging as one of the fastest-growing segments within the broader health and wellness industry; however, certain challenges persist. Historically, women have been underrepresented in clinical trials, leading to a lack of data specifically focused on female health conditions. Most nutraceutical and pharmaceutical products have been primarily studied in men only, resulting in an insufficient understanding of how these products affect women differently, leading to misdiagnoses, ineffective treatments, and adverse effects. As per the World Economic Forum's "Closing the Women's Health Gap 2024" report, US women have 52% more adverse events and 36% more serious or fatal events from approved medicines than men. Also, the report mentions that women spend 25% more of their lives in poor health than men. The industry's challenge is to close this gap by developing products that are safe and effective for women, particularly in areas such as reproductive health, hormonal balance, and menopause induced bone health.
This Global Women's Health Nutraceutical Ingredients Market study focuses on addressing the specific nutritional needs of women across different stages of life, from adolescence through the childbearing years to menopause and beyond. The market is ripe with opportunities, with projected strong growth during the forecast period (2025-2031).